Advertisement
New Zealand markets open in 1 hour 36 minutes

  • NZX 50

    11,836.04
    -39.31 (-0.33%)
     

  • NZD/USD

    0.5903
    -0.0016 (-0.27%)
     

  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     

  • OIL

    82.68
    -0.01 (-0.01%)
     

  • GOLD

    2,394.90
    +6.50 (+0.27%)
     

Why Gap, Inc. (GPS) is Such a Great Value Stock Pick Right Now

Zacks Equity Research
Updated

Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends?

Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; Gap, Inc. GPS.

Gap in Focus

GPS may be an interesting play thanks to its forward PE of 11.61, its P/S ratio of 0.75, and its decent dividend yield of 3.01%. These factors suggest that Gap is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that GPS has decent revenue metrics to back up its earnings.

The Gap, Inc. PE Ratio (TTM)

The Gap, Inc. PE Ratio (TTM) | The Gap, Inc. Quote

ADVERTISEMENT

But before you think that Gap is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has gone up by 13.9% in the past 30 days, thanks to 13 upward revisions in the past one month compared to none lower.

This estimate strength is actually enough to push GPS to a Zacks Rank #2 (Buy), suggesting it is poised to outperform. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So really, Gap is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Gap, Inc. (GPS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.